Matthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M
Biomedicines. 2021; 9(12).
PMID: 34944765
PMC: 8698579.
DOI: 10.3390/biomedicines9121949.
Qin M, Wang D, Fang Y, Zheng Z, Liu X, Wu F
Front Oncol. 2021; 11:647854.
PMID: 34235074
PMC: 8256159.
DOI: 10.3389/fonc.2021.647854.
Fitzpatrick E, Wang J, Strome S
Front Immunol. 2020; 11:496.
PMID: 32269572
PMC: 7109252.
DOI: 10.3389/fimmu.2020.00496.
Dou X, Tong P, Huang H, Zellmer L, He Y, Jia Q
J Cancer. 2020; 11(10):2887-2920.
PMID: 32226506
PMC: 7086263.
DOI: 10.7150/jca.41324.
Platt J, de Mattos Barbosa M, Cascalho M
Immunol Rev. 2019; 292(1):180-193.
PMID: 31609002
PMC: 10387221.
DOI: 10.1111/imr.12813.
Non-canonical B cell functions in transplantation.
Platt J, Cascalho M
Hum Immunol. 2019; 80(6):363-377.
PMID: 30980861
PMC: 6544480.
DOI: 10.1016/j.humimm.2019.04.006.
B cell regulation in cancer and anti-tumor immunity.
Sarvaria A, Madrigal J, Saudemont A
Cell Mol Immunol. 2017; 14(8):662-674.
PMID: 28626234
PMC: 5549607.
DOI: 10.1038/cmi.2017.35.
Fc receptors as adaptive immunoreceptors.
Daeron M
Curr Top Microbiol Immunol. 2014; 382:131-64.
PMID: 25116099
PMC: 7120570.
DOI: 10.1007/978-3-319-07911-0_7.
Prognostic impact of B-cell density in cutaneous melanoma.
Ladanyi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K
Cancer Immunol Immunother. 2011; 60(12):1729-38.
PMID: 21779876
PMC: 11028465.
DOI: 10.1007/s00262-011-1071-x.
DEMONSTRATION OF MOUSE ISOANTIGENS AT THE CELLULAR LEVEL BY THE FLUORESCENT ANTIBODY TECHNIQUE.
Moller G
J Exp Med. 2009; 114(4):415-34.
PMID: 19867192
PMC: 2180360.
DOI: 10.1084/jem.114.4.415.
DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT.
Snell G, Winn H, Stimpfling J, Parker S
J Exp Med. 2009; 112(2):293-314.
PMID: 19867173
PMC: 2137227.
DOI: 10.1084/jem.112.2.293.
Immunoglobulin expression in non-lymphoid lineage and neoplastic cells.
Chen Z, Qiu X, Gu J
Am J Pathol. 2009; 174(4):1139-48.
PMID: 19246641
PMC: 2671347.
DOI: 10.2353/ajpath.2009.080879.
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.
DeNardo D, Coussens L
Breast Cancer Res. 2007; 9(4):212.
PMID: 17705880
PMC: 2206719.
DOI: 10.1186/bcr1746.
The interplay between innate and adaptive immunity regulates cancer development.
de Visser K, Coussens L
Cancer Immunol Immunother. 2005; 54(11):1143-52.
PMID: 15889249
PMC: 11032791.
DOI: 10.1007/s00262-005-0702-5.
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.
Ichim C
J Transl Med. 2005; 3(1):8.
PMID: 15698481
PMC: 549049.
DOI: 10.1186/1479-5876-3-8.
Quantitative studies of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of isoantibodies.
Moller E, Moller G
J Exp Med. 1962; 115:527-53.
PMID: 14475217
PMC: 2137496.
DOI: 10.1084/jem.115.3.527.
Host desensitization as a means of augmenting tissue homotransplantation: donor spleen tissue as the desensitizing antigen.
MARSHALL 2nd F
Ann Surg. 1962; 155:289-95.
PMID: 14470246
PMC: 1466054.
DOI: 10.1097/00000658-196200000-00019.
Active and passive immunity to transplantation of foreign bone marrow in lethally irradiated mice.
LOUTIT J, Micklem H
Br J Exp Pathol. 1961; 42:577-86.
PMID: 14466840
PMC: 2082463.
The antigenic structure of a transplanted sarcoma.
OGorman P, MIKULSKA Z
Br J Cancer. 1960; 14:121-5.
PMID: 14428078
PMC: 2074135.
DOI: 10.1038/bjc.1960.14.
[Electronoptic studies on ascites tumor cells after the action of heterologic antisera].
LOEBLICH H, LANDSCHUETZ C
Z Krebsforsch. 1960; 63:335-44.
PMID: 14417855
